Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
MS News Roundup, Week of June 26th - July 2nd
Manage episode 411747278 series 3344953
Welcome to this week's episode of the Multiple Sclerosis Weekly Update, where we cover the most recent and impactful news related to MS. This week, we delve into a groundbreaking study that reveals a genetic variant influencing the severity and progression of MS in certain patients. We also unpack a legal dispute between Biogen and Novartis over the biosimilar of Tysabri and explore what this means for branded biologic-drug makers. Additionally, we discuss the surprising impact of myelin on axons in MS, compare the efficacy of rituximab and ocrelizumab, and reflect on Christina Applegate's journey with MS. Stay tuned for these stories and more in this week's episode.
Here are the like to the articles:
https://www.healthline.com/health-news/ms-symptoms-progress-more-quickly-in-certain-people-researchers-think-they-know-why
https://news.bloomberglaw.com/health-law-and-business/details-emerge-in-biogens-failure-to-block-biosimliar-tysabri
https://www.news-medical.net/news/20230630/Myelin-can-be-harmful-to-axons-in-multiple-sclerosis.aspx
https://www.physiciansweekly.com/comparing-the-efficacy-of-rituximab-and-ocrelizumab-for-relapsing-remitting-multiple-sclerosis/
https://www.sportskeeda.com/health-and-fitness/news-david-faustino-speaks-christina-applegate-s-struggle-multiple-sclerosis-diagnosis
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
54 tập
Manage episode 411747278 series 3344953
Welcome to this week's episode of the Multiple Sclerosis Weekly Update, where we cover the most recent and impactful news related to MS. This week, we delve into a groundbreaking study that reveals a genetic variant influencing the severity and progression of MS in certain patients. We also unpack a legal dispute between Biogen and Novartis over the biosimilar of Tysabri and explore what this means for branded biologic-drug makers. Additionally, we discuss the surprising impact of myelin on axons in MS, compare the efficacy of rituximab and ocrelizumab, and reflect on Christina Applegate's journey with MS. Stay tuned for these stories and more in this week's episode.
Here are the like to the articles:
https://www.healthline.com/health-news/ms-symptoms-progress-more-quickly-in-certain-people-researchers-think-they-know-why
https://news.bloomberglaw.com/health-law-and-business/details-emerge-in-biogens-failure-to-block-biosimliar-tysabri
https://www.news-medical.net/news/20230630/Myelin-can-be-harmful-to-axons-in-multiple-sclerosis.aspx
https://www.physiciansweekly.com/comparing-the-efficacy-of-rituximab-and-ocrelizumab-for-relapsing-remitting-multiple-sclerosis/
https://www.sportskeeda.com/health-and-fitness/news-david-faustino-speaks-christina-applegate-s-struggle-multiple-sclerosis-diagnosis
The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.
www.justmultiplesclerosis.com
54 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.